<p>MCF-7 cells were treated with Mitocur-1 (5 and 10 µM) for a period of 24 h. (<b>A</b>) shows the flow cytometry profiles of (PI)- stained cells of control, and Mitocur-1 (5 and 10 µM) treatment as described in Methods. (<b>B</b>) Quantitative cell cycle (DNA content) distribution (% of total) in the control and treatment groups. (<b>C</b>) MCF-7 cells were treated with Mitocur-1 (5 and 10 µM) for 24 h and subjected to Western blot analysis. Representative immunoblot images of cyclin A, cyclin B1 and cyclin D1 are shown. Values are expressed Mean ± SD; (n = 4). **, significantly different from control (P<0.01).</p
<p>(A and B) Cell cycle distribution of U937 cells treated with MBL. FCM analysis of the cell cycle ...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p><b>(A)</b> Real-time proliferation curves as determined by <i>xCELLigence</i> RTCA. Changes in an...
<p>MCF-7 cells (left) and LN229 cells (right) were left untreated (top) or treated with the indicate...
<p>SMCs were kept as controls or on fibrillar collagen with NG- or HG-MCM treatment. Cells were anal...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>MCF-7 cells were treated with <b>PNAP</b>-<b>1</b>, -<b>3h</b>, and -<b>6h</b> at three concentra...
<p>A549 and H460 cells were treated with CCL21 (100 ng/mL) for 24 h, and cell cycle distribution was...
<p>Cells were treated with or without 2.5 μM MPT0B169 for 24 and 48 h, and the following experiments...
<p>Cells were treated with (A) 0.1% vehicle DMSO (control) for 48 h and annomuricin E at the IC<sub>...
<p>(A) Flow cytometric cell cycle analysis. Two-day post-confluent 3T3-L1 preadipocytes were incubat...
<p>Flow cytometric analysis of cell cycle was performed in control and TamR cells after treatment wi...
<p>(A) Cells were exposed to 0–40 µM of Andro for 48 h; (B) cells were exposed to 40 µM of Andro for...
<p>MCF-7 cells were treated with 750 µg/ml for 48 h. followed by treatment with RNase (100 µg/ml) an...
<p>(A and B) Cell cycle distribution of U937 cells treated with MBL. FCM analysis of the cell cycle ...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p><b>(A)</b> Real-time proliferation curves as determined by <i>xCELLigence</i> RTCA. Changes in an...
<p>MCF-7 cells (left) and LN229 cells (right) were left untreated (top) or treated with the indicate...
<p>SMCs were kept as controls or on fibrillar collagen with NG- or HG-MCM treatment. Cells were anal...
<p><b>A</b> Cell cycle analysis of 5TGM1 cells treated with 0, 200 or 400 nM of MTM. Cells were trea...
<p>Cell cycle distribution of control and AQHAR-treated U2OS (A and C) and TIG-3 (B and D) cells are...
<p>MCF-7 cells were treated with <b>PNAP</b>-<b>1</b>, -<b>3h</b>, and -<b>6h</b> at three concentra...
<p>A549 and H460 cells were treated with CCL21 (100 ng/mL) for 24 h, and cell cycle distribution was...
<p>Cells were treated with or without 2.5 μM MPT0B169 for 24 and 48 h, and the following experiments...
<p>Cells were treated with (A) 0.1% vehicle DMSO (control) for 48 h and annomuricin E at the IC<sub>...
<p>(A) Flow cytometric cell cycle analysis. Two-day post-confluent 3T3-L1 preadipocytes were incubat...
<p>Flow cytometric analysis of cell cycle was performed in control and TamR cells after treatment wi...
<p>(A) Cells were exposed to 0–40 µM of Andro for 48 h; (B) cells were exposed to 40 µM of Andro for...
<p>MCF-7 cells were treated with 750 µg/ml for 48 h. followed by treatment with RNase (100 µg/ml) an...
<p>(A and B) Cell cycle distribution of U937 cells treated with MBL. FCM analysis of the cell cycle ...
<p>HCT116 and p53KO cells were incubated in 15 μM IGG, 30 μM IGG or vehicle control for either 8 or ...
<p><b>(A)</b> Real-time proliferation curves as determined by <i>xCELLigence</i> RTCA. Changes in an...